World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   10017 records for 2160 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusMain ID Public TitleDate of Registration
RecruitingRBR-3p8g7n
Clinical Trial of Telavancin Versus Standard Intravenous Therapy in the Treatment of Subjects with Staphylococcus aureus Bacteremia Including Infective Endocarditis
03/08/2016
RecruitingNCT02837445
Moderato System: A Double-Blind Randomized Trial
08/07/2016
Not RecruitingJPRN-JapicCTI-152974
An Open-Label, Multicenter Extension Study of Onartuzumab in Patients with Solid Tumors on Study Treatment Previously Enrolled in an F. Hoffmann-La Roche- AND/OR Genentech-Sponsored Study
Recruitment statusMain IDPublic titleDate of registration
Not recruitingNCT02488330An Extension Study of Onartuzumab in Patients With Solid Tumors on Study Treatment Previously Enrolled in a Company Sponsored Study30/06/2015
01/07/2016
RecruitingNCT02825628
Study of ODX (Osteodex) in Metastatic Castration Resistant Prostate Cancer (CRPC)
27/06/2016
AuthorisedEUCTR2016-000390-20-PL
English A Phase 2a, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Symptomatic Ulcerative Colitis Patients with Moderate to Severe Disease Activity 16/06/2016
AuthorisedEUCTR2015-005666-37-EE
A double-blind, multi-centre phase II dose finding study of ODX (Osteodex) in for patients with castration resistant prostate cancer and skeletal metastates
16/06/2016
AuthorisedEUCTR2016-000390-20-HU
A Phase 2a, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Symptomatic Ulcerative Colitis Patients with Moderate to Severe Disease Activity 14/06/2016
RecruitingISRCTN81005631
The evaluation of the potential damage to vascular wall in the perioperative settings during periods of dehydration and following infusion of cristalloid solutions during general anaesthesia
10/06/2016
AuthorisedEUCTR2015-004147-40-ES
A clinical trial comparing X-396 (study drug) to Crizotinib in lung cancer patients.
09/06/2016
AuthorisedEUCTR2015-004782-92-HU
Bacterial Pneumonia treatment with a new antibiotic compared to an existing one.
09/06/2016
    
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history